Skip to main content
Book Chapter

SMART Drug Design: Novel Phosphopeptide and ATP Mimetic-Based Small Molecule Inhibitors of the Oncogenic Protein Kinase pp60src (Src)

  • Sawyer T
  • Bohacek R
  • Shakespeare W
  • et al.
Springer US, (2005), 219-253
DOI: 10.1007/0-387-24532-4_11
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Over the past two decades, the oncogenic protein kinase pp60src (Src) has been the focus of tremendous biological investigations that have identified it to be a promising therapeutic target for both cancer and bone disease drug discovery. The molecular, cellular and...

Cite

CITATION STYLE

APA

Sawyer, T. K., Bohacek, R. S., Shakespeare, W. C., Metcalf, C. A., Wang, Y., Sundaramoorthi, R., … Dalgarno, D. C. (2005). SMART Drug Design: Novel Phosphopeptide and ATP Mimetic-Based Small Molecule Inhibitors of the Oncogenic Protein Kinase pp60src (Src). In Proteomics and Protein-Protein Interactions (pp. 219–253). Springer US. https://doi.org/10.1007/0-387-24532-4_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free